Dr Amy Gerrish and her team have been working to develop a form of liquid biopsy, using cell-free DNA (cfDNA) found in eye fluid, to discover if a patient has the heritable or non-heritable form of retinoblastoma (Rb). This information is vital in identifying...
Professor Jesse Berry determines the superiority of the aqueous humour as a source of tumour DNA and explains her findings from her CHECT-funded research. Developing a liquid biopsy for retinoblastoma (Rb) would help us to overcome two current clinical problems: 1)...
We hear from Dr Agata Rozanka, part of Professor Lako’s team at Newcastle University, about the CHECT-funded retinoblastoma project they have just completed, and what the next steps will be. Although there are many successful treatments for retinoblastoma, these...
We are delighted to announce the latest CHECT-funded research project on retinoblastoma drug development, which will be starting in January 2023. Professor Seigel, from the University at Buffalo, USA, describes her project below. One challenge in developing new...
You may remember last year we told you about ways in which you and your child could get involved in telling researchers what you think should be the priorities for childhood cancer research. The project was funded and run by the Childhood Cancer and Leukaemia Group...
It’s all change on CHECT’s Scientific Advisory Committee this year! In July we sadly said goodbye to Prof Lorna Fraser, who had spent six years as Chair of the SAC (the body that oversees our research). As well as bringing her immense professional expertise to the...
